Ensuring Access to Clinical Trials Act of 2015
Became Public Law No: 114-63.
PUB 114-63Became Public Law No: 114-63.
Became Public Law No: 114-63.

Signed by President.
Signed by President.
Became Public Law No: 114-63.
Became Public Law No: 114-63.
Presented to President.
Presented to President.
Mr. Ryan (WI) moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H6276-6279)
DEBATE - The House proceeded with forty minutes of debate on S. 139.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6276)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6276)
Motion to reconsider laid on the table Agreed to without objection.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Received in the House.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Message on Senate action sent to the House.
Senate Committee on Finance discharged by Unanimous Consent.
Senate Committee on Finance discharged by Unanimous Consent.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5175; text as passed Senate: CR S5175)
Passed Senate without amendment by Unanimous Consent. (consideration: CR S5175; text as passed Senate: CR S5175)
Introduced in Senate
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S105; text of measure as introduced: CR S105)